Reps. Henry Waxman, D-Calif., and Ed Markey, D-Mass., have introduced a bill that would allow the FDA to prohibit drug companies from running direct-to-consumer ads for new pharmaceuticals for up to three years. A similar bill in the Senate would allow ad prohibitions for up to two years. Both bills would require the FDA to clear drug ads before they appear in public.

Related Summaries